Dear colleagues and friends,
adjusted to the times of a serious pandemic with the aim to protect clinicians and scientists and their teams, our international conference on advanced retinal therapy (ART 2020) has been converted to a virtual meeting. Yet, simultaneous to restrictions and lock-downs, research and progress continues in the most powerful manner and brings a new rhythm into the old system.
Obviously, a conference on “advanced” therapy will take full benefit of the dynamic digital times!
In general, the field of retina has been greatly blessed with innovation during recent years. Break-throughs in diagnostic imaging as well as in technologies such as artificial intelligence (AI) and gene therapy continue finding most constructive grounds in ophthalmology.
For this year’s conference, we will, for a good reason, focus on current perspectives in AI and our experiences with its potential to support clinical diagnosis, not only in ophthalmic conditions, but also in ocular manifestation of systemic diseases. The retina, a window to the body, has become a playground for clinical scientists and computer specialists who are developing AI algorithms for diagnosis of ocular, but even more so the leading systemic diseases of industrialized countries such as diabetes, cardiovascular disease and neurodegeneration.
This is clearly introducing a large paradigm shift in medicine and in the society, which will be the Keynote Lecture at ART 2020 given by the author Marlene Streeruwitz.
Despite the discovery of novel grounds, solid expertise and experience is the base of quality in medicine. Known experts in the field will therefore share their knowledge with their colleagues for training and learning, by the way, a common motif in AI as well.
The good will and flexibility of our speakers and audience will enable the community to move through harsh times safely while maintaining and further advancing scientific curiosity and medical responsibility.
Looking forward to see and listen to you in personalized virtuality,
Univ.-Prof. Dr. Ursula Schmidt-Erfurth
Professor and Chair
Medical University Vienna
Department of Ophthalmology and Optometry
Robert Miller Professor
Feinberg School of Medicine
Northwestern University Chicago
Austrian Academy of Sciences
- 09:30-09:40 | Ursula Schmidt-Erfurth: Welcome and opening
- 09:40-10:00 | Alexander Brucker: The big Five in retina: An editor’s choice
Session 1 - AI in retina
Moderator: Hrvoje Bogunovic, Bianca Gerendas
- 10:00-10:15 | Tien Y. Wong: AI insights into life and death: Systemic disease seen in the retina
- 10:15-10:30 | Gemmy Cheung: Diabetic retinopathy screening: Here to stay
- 10:30-10:45 | R. Theodore Smith: Predicting disease progression in AMD using AI
- 10:45-11:00 | Felipe A. Medeiros: A role model: AI in glaucoma
- 11:00-11:15 | Pearse Keane: How do ophthalmologists compare with AI Aaron Y. Lee
- 11:15-11:30 | Aaron Y. Lee: Challenges/risks in AI in retinal disease: a down-to-earth perspective
- 11:30-12:00 | EXPERT round-table and PANEL discussion
Keynote Lecture - Another horizon in AI
- 12:30-12:50 | Marlene Streeruwitz: The Duplication of Man
- 12:50-13:00 | Intermission
Session 2 – Medical Retina
Moderator: Ursula Schmidt-Erfurth, Andreas Pollreisz
- 13:00-13:15 | Glenn Jaffe: The Port Delivery System versus injections
- 13:15-13:30 | Amani Fawzi: OCTA learnings in diabetic retinal disease
- 13:30-13:45 | Dante Pieramici: Prevention of neovascular conversion in AMD by anti-VEGF therapy
- 13:45-14:00 | Jennifer Sun: Conclusions on anti-VEGF therapy for non-proliferative PDR
- 14:00-14:15 | Nancy Holekamp: An update on retinal gene therapy
- 14:15-14:30 | Jeffrey Heier: Beyond the anti-VEGF era
- 14:30-15:00 | EXPERT round-table and PANEL discussion
Session 3 – Surgery
Moderator: Stefan Sacu, Michael Georgopoulos
- 15:30-15:45 | David Wong: Role and risks in pneumatic retinopexie
- 15:45-16:00 | Stanislao Rizzo: Surgery in the myopic eye
- 16:00-16:15 | Jean-Pierre Hubschman: Macular surgery: Insights from advanced imaging
- 16:15-16:30 | Yannek Leiderman: AI-based guidance in vitreoretinal surgery